Genomic Landscape of Ovarian Cancer

作者: Delia Mezzanzanica , Loris De Cecco , Marina Bagnoli , Patrizia Pinciroli , Marco A. Pierotti

DOI: 10.1007/978-94-007-5842-1_10

关键词:

摘要: Epithelial ovarian cancer (EOC) remains one of the most challenging areas research as it is a highly heterogeneous disease from both molecular and etiological points view. Furthermore, EOC fifth leading cause cancer-related deaths among women, death gynecological cancer. Early detection paramount to increase survival, but only 25% all are found at an early stage; furthermore, tumors that appear similar based on traditional clinical histopathologic features may respond very differently therapy. At biological level, relevant need for new classification would enable identification targetable pathways predict outcome disease; open issues patients with drug-resistant cancers so alternative therapeutic modalities can be offered.

参考文章(153)
K R Cho, T D Kessis, L Hedrick, R T Burks, Microsatellite instability in endometrial carcinoma. Oncogene. ,vol. 9, pp. 1163- 1166 ,(1994)
Sharon L R Kardia, David E. Misek, Samir M. Hanash, George Michailidis, Rork Kuick, Eric R. Fearon, Kerby A. Shedden, Thomas J. Giordano, Danielle M. Darrah, Kathleen R. Cho, Yali Zhai, Jeremy M G Taylor, Lora H. Ellenson, Heather Reed, Donald R. Schwartz, Rong Wu, Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Research. ,vol. 62, pp. 4722- 4729 ,(2002)
Tae Heon Kim, Yu Kyung Kim, Youngdo Kwon, Jin Hyung Heo, Haeyoun Kang, Gwangil Kim, Hee Jung An, Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours Histopathology. ,vol. 57, pp. 734- 743 ,(2010) , 10.1111/J.1365-2559.2010.03686.X
Ie-Ming Shih, Robert J. Kurman, Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis American Journal of Pathology. ,vol. 164, pp. 1511- 1518 ,(2004) , 10.1016/S0002-9440(10)63708-X
George S Watts, Bernard W Futscher, Nicholas Holtan, Koen DeGeest, Frederick E Domann, Stephen L Rose, DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage BMC Medical Genomics. ,vol. 1, pp. 47- 47 ,(2008) , 10.1186/1755-8794-1-47
Young-Jeong Na, John Farley, Audrey Zeh, Marcela del Carmen, Richard Penson, Michael J. Birrer, Ovarian cancer: markers of response. International Journal of Gynecological Cancer. ,vol. 19, ,(2009) , 10.1111/IGC.0B013E3181C2AEB5
A Kallioniemi, O. Kallioniemi, D Sudar, D Rutovitz, J. Gray, F Waldman, D Pinkel, Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors Science. ,vol. 258, pp. 818- 821 ,(1992) , 10.1126/SCIENCE.1359641
S. C. Mok, J. Chao, S. Skates, K.-k. Wong, G. K. Yiu, M. G. Muto, R. S. Berkowitz, D. W. Cramer, Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology Journal of the National Cancer Institute. ,vol. 93, pp. 1458- 1464 ,(2001) , 10.1093/JNCI/93.19.1458
A V Khrunin, A Moisseev, V Gorbunova, S Limborska, Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients Pharmacogenomics Journal. ,vol. 10, pp. 54- 61 ,(2010) , 10.1038/TPJ.2009.45
Bríd M. Ryan, Ana I. Robles, Curtis C. Harris, Genetic variation in microRNA networks: the implications for cancer research Nature Reviews Cancer. ,vol. 10, pp. 389- 402 ,(2010) , 10.1038/NRC2867